Class information for:
Level 2: CARVEDILOL//NEBIVOLOL//BETA BLOCKERS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
895 10656 28.4 51%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
24 112627 HYPERTENSION//JOURNAL OF HYPERTENSION//HEART FAILURE

Classes in level below (level 1)


ID, lev. below Publications Label for level below
3713 1847 CARVEDILOL//BUCINDOLOL//CARVEDILOL ENANTIOMERS
5326 1571 DOXAZOSIN//AJ 2615//MONATEPIL MALEATE
7798 1248 RECEPTOR OCCUPANCY THEORY//DIACETOLOL//TERNARY COMPLEX MODEL
11941 879 COLLATERAL CORONARY FLOW//ADV MED TRAINING STATE//BETA BLOCKER
12656 828 ATENOLOL//ALPHA HYDROXYMETOPROLOL//ACEBUTOLOL HYDROCHLORIDE
13417 774 AMOSULALOL//TERTATOLOL//DILEVALOL
18376 489 CELIPROLOL//BEVANTOLOL//PERINDOPRIL THERAPEUTIC USE
18559 480 MED HOSP PHARM YAHATANISHI KU//4 HYDROXYPROPRANOLOL//PROPRANOLOL METABOLISM
18663 475 ANTIHYPERTENSIVE PHARMACOTHERAPY//BETA1 BLOCKADE//CARDIOVASC P REHABIL UNIT
19038 458 NEBIVOLOL//VASODILATING BETA BLOCKERS//NEBIVOLOL HYDROCHLORIDE
20710 388 BISOPROLOL//CARDIOSELECTIVE BETA BLOCKERS//CARDIOSELECTIVE
22827 311 BOPINDOLOL//NIPRADILOL//H 3 CGP12177
24798 251 REDUCTIVE RING CLOSURE//THERMAL CYCLISATION//PHENOXYBENZAMINE HYDROCHLORIDE
27532 186 DOXAZOSIN MESYLATE//SELECTIVE ALPHA1 BLOCKERS//ALFUZOSIN HYDROCHLORIDE
29789 147 APEXCARDIOGRAPHY//HANDGRIP APEXCARDIOGRAPHIC TEST//DOPPLER ECHO
31385 123 ALPHA BETA ADRENOCEPTOR BLOCKADE//KMUP 1//EUGENOSEDIN A
31433 123 AROTINOLOL//SHICHIMOTSU KOKA TO//SHICHIMOTSUKOKATO
34120 78 ABT MED FOR//CARDIOSELECTIVE BETA RECEPTOR ANTAGONIST//PAREXEL GMBH

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 CARVEDILOL Author keyword 316 50% 4% 459
2 NEBIVOLOL Author keyword 235 64% 2% 229
3 BETA BLOCKERS Author keyword 87 20% 4% 397
4 METOPROLOL Author keyword 58 26% 2% 194
5 BISOPROLOL Author keyword 56 41% 1% 104
6 CELIPROLOL Author keyword 45 54% 1% 58
7 ATENOLOL Author keyword 39 20% 2% 174
8 BETA BLOCKER Author keyword 35 16% 2% 197
9 BOPINDOLOL Author keyword 34 79% 0% 22
10 DOXAZOSIN Author keyword 25 25% 1% 90

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 CARVEDILOL 316 50% 4% 459 Search CARVEDILOL Search CARVEDILOL
2 NEBIVOLOL 235 64% 2% 229 Search NEBIVOLOL Search NEBIVOLOL
3 BETA BLOCKERS 87 20% 4% 397 Search BETA+BLOCKERS Search BETA+BLOCKERS
4 METOPROLOL 58 26% 2% 194 Search METOPROLOL Search METOPROLOL
5 BISOPROLOL 56 41% 1% 104 Search BISOPROLOL Search BISOPROLOL
6 CELIPROLOL 45 54% 1% 58 Search CELIPROLOL Search CELIPROLOL
7 ATENOLOL 39 20% 2% 174 Search ATENOLOL Search ATENOLOL
8 BETA BLOCKER 35 16% 2% 197 Search BETA+BLOCKER Search BETA+BLOCKER
9 BOPINDOLOL 34 79% 0% 22 Search BOPINDOLOL Search BOPINDOLOL
10 DOXAZOSIN 25 25% 1% 90 Search DOXAZOSIN Search DOXAZOSIN

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 METOPROLOL 278 37% 6% 595
2 CARVEDILOL 187 33% 4% 465
3 BUCINDOLOL 108 75% 1% 78
4 BETA ADRENOCEPTOR ANTAGONIST 95 67% 1% 85
5 ADRENERGIC BLOCKADE 73 36% 2% 166
6 MERIT HF 71 47% 1% 114
7 CARDIAC INSUFFICIENCY BISOPROLOL 62 50% 1% 89
8 ATENOLOL 61 22% 2% 250
9 RANDOMIZED INTERVENTION TRIAL 59 45% 1% 98
10 BETA BLOCKERS 56 16% 3% 331

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
BETA-BLOCKADE DURING AND AFTER MYOCARDIAL-INFARCTION - AN OVERVIEW OF THE RANDOMIZED TRIALS 1985 2072 36 83%
beta-adrenergic receptor blockade in chronic heart failure 2000 582 82 66%
Propranolol and central nervous system function: potential implications for paediatric patients with infantile haemangiomas 2015 5 59 22%
Heart Failure and Chronic Obstructive Pulmonary Disease 2011 51 87 49%
Meta-Analysis of Carvedilol Versus Beta 1 Selective Beta-Blockers (Atenolol, Bisoprolol, Metoprolol, and Nebivolol) 2013 26 24 54%
Different pharmacological properties of two enantiomers in a unique beta-blocker, nebivolol 2008 37 61 92%
Carvedilol 1998 163 60 80%
Beta-blocker use and COPD mortality: a systematic review and meta-analysis 2012 22 19 63%
Expert consensus document on beta-adrenergic receptor blockers 2004 249 173 36%
beta-blocker therapy in heart failure - Scientific review 2002 158 70 54%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 MED HOSP PHARM YAHATANISHI KU 5 60% 0.1% 6
2 CLIN SCI STUDY OPERAT 3 57% 0.0% 4
3 CLIN PHARMACOKINET MODELING SIMULAT 3 43% 0.1% 6
4 EDUC NATIONALITIES 3 100% 0.0% 3
5 PHYSIOPATHOL CLIN BIOCHEM 3 38% 0.1% 6
6 MICHIGAN HEART FAILURE TRANSPLANT CARE 3 50% 0.0% 4
7 CLIN PHARMACOL STAT PROGRAMMING 2 38% 0.0% 5
8 CARDIOL SPORT MED 2 28% 0.1% 7
9 ATLANTA VASC FDN 2 67% 0.0% 2
10 BIOMED SURG SCI MED D 2 67% 0.0% 2

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000016150 TORASEMIDE//HYPERKALEMIA//FUROSEMIDE
2 0.0000013808 CALCIUM ANTAGONISTS//AMLODIPINE//ISRADIPINE
3 0.0000013752 LEVOSIMENDAN//CALCIUM SENSITIZERS//CALCIUM SENSITIZER
4 0.0000011968 HEART FAILURE//NATRIURETIC PEPTIDES//B TYPE NATRIURETIC PEPTIDE
5 0.0000010997 DRUG INDUCED DEPRESSION//BUZEPIDE METHIODIDE//DEPRESSIVE DISORDER CHEMICALLY INDUCED
6 0.0000010399 HEREDITARY ANGIOEDEMA//C1 INHIBITOR//ANGIOEDEMA
7 0.0000010189 IVABRADINE//SINOATRIAL NODE//HCN CHANNELS
8 0.0000009813 LEFT VENTRICULAR HYPERTROPHY//POST EXERCISE HYPOTENSION//LEFT VENTRICULAR MASS
9 0.0000009662 MEDICATION ADHERENCE//JOURNAL OF HUMAN HYPERTENSION//BLOOD PRESSURE CONTROL
10 0.0000009047 CHLOROETHYLCLONIDINE//ALPHA1 ADRENOCEPTOR SUBTYPE//BETA3 ADRENOCEPTORS